Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.
about
Turning receptors on and off with intracellular pepducins: new insights into G-protein-coupled receptor drug developmentEnteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implicationsKallikrein 6 signals through PAR1 and PAR2 to promote neuron injury and exacerbate glutamate neurotoxicity.Suppression of arterial thrombosis without affecting hemostatic parameters with a cell-penetrating PAR1 pepducin.Matrix metalloprotease 1a deficiency suppresses tumor growth and angiogenesis.CCAAT/enhancer-binding protein-α suppresses lung tumor development in mice through the p38α MAP kinase pathway.Targeting CXCR4 with cell-penetrating pepducins in lymphoma and lymphocytic leukemia.Inhibition of lethal inflammatory responses through the targeting of membrane-associated Toll-like receptor 4 signaling complexes with a Smad6-derived peptide.Allosteric Activation of a G Protein-coupled Receptor with Cell-penetrating Receptor MimeticsMatrix metalloprotease-1a promotes tumorigenesis and metastasis.Potential importance of protease activated receptor (PAR)-1 expression in the tumor stroma of non-small-cell lung cancer.Interdicting Gq Activation in Airway Disease by Receptor-Dependent and Receptor-Independent Mechanisms.Pepducin targeting the C-X-C chemokine receptor type 4 acts as a biased agonist favoring activation of the inhibitory G protein.New strategies to develop novel pain therapies: addressing thermoreceptors from different points of view.Endothelial barrier dysfunction in septic shock.Protease receptor antagonism to target blood platelet therapies.Platelet-targeted pharmacologic treatments as anti-cancer therapy.Proinflammatory signaling functions of thrombin in cancer.Targeting PAR1: Now What?Regulation of the Melanocortin-Sensitive Adenylate Cyclase System by N-Acylated Peptide 71-82 of Type 4 Melanocortin Receptor.Pepducins and Other Lipidated Peptides as Mechanistic Probes and Therapeutics.Dabigatran potentiates gemcitabine-induced growth inhibition of pancreatic cancer in mice.Dysregulated protease activated receptor 1 (PAR1) promotes metastatic phenotype in breast cancer through HMGA2.Palmitoylated peptide 562-572 of luteinizing hormone receptor increases testosterone level in male rats.Thromboxane A2 receptor-mediated release of matrix metalloproteinase-1 (MMP-1) induces expression of monocyte chemoattractant protein-1 (MCP-1) by activation of protease-activated receptor 2 (PAR2) in A549 human lung adenocarcinoma cells.Authors' reply-Re: Shi et al. Protease-activated receptor 2 suppresses lymphangiogenesis and subsequent lymph node metastasis in a murine pancreatic cancer model. J Pathol 2014;234: 398-409.Role of the extracellular signal-regulated kinase 1/2 signaling pathway in the process of thrombin-promoting airway remodeling in ovalbumin-allergic rats.PAR1 signaling on tumor cells limits tumor growth by maintaining a mesenchymal phenotype in pancreatic cancer
P2860
Q27024397-21B7C812-9EEE-40F8-9273-108FE88494A0Q27027602-A16CAD9A-A6FA-4C0E-AC3F-290FABA57840Q33898352-E91A5AD1-4D60-4346-A75F-516D264E345BQ34282119-C962BF11-D7CA-4450-957D-3ADADC384FDAQ34457039-D6470632-C426-42F3-B6EF-C98DE9E834ABQ34599904-F4BD793D-927C-4795-B602-5A69596BEA18Q35776992-3A1E8469-47E7-48C9-B8EE-D9B67C9ECCD8Q35822572-6E0BC208-4526-4A2D-B312-5652C8459769Q35860717-F8E66D63-ABC6-4876-B086-7AC855A81DF3Q36097959-AA991D0B-954A-44FB-A96C-2A696C039057Q36273274-D21A3D05-6528-4685-ABC9-A722A93160C0Q36432415-74CAFF62-B568-4CA0-A29B-58375F06F9E9Q37421226-2B6563C4-9E57-4735-A27B-62D4702619AEQ38167283-F3FE003A-D3A5-4795-8F5E-688AAF2E73FDQ38270705-367BC0BC-B96E-46EC-BB46-3482EECA8B3CQ38616508-F0ADA4DE-D307-4979-BF55-1468BB12B1EFQ38657846-AE8AC6F1-D3E6-455E-B39F-67130FBECE6CQ39048394-63EAF941-B17E-4D89-B5E4-59BFC4A51E27Q39338913-9D9F26E0-6797-4413-B10A-48439DAEC756Q40290455-B7C640AA-49E8-408E-BBE2-4E0DBA153E31Q40405065-DA52234F-4F3C-442E-B912-ED739DB3BF0AQ42314537-C2C6548E-EE6D-4407-9DC9-2BB868997BAFQ42479614-A1D7471F-6DCB-482E-A17D-EFA7563DA381Q43920446-54F6BB78-16F3-454D-82EB-DAC00FD4044AQ43963683-1BBCC1FD-D04A-4499-85C1-89410905B96EQ53668958-1CF2B325-090E-4CBC-8A8E-65E439E9DF42Q55069208-9BC90126-1BAC-4C7C-B2DC-542EFBAA9D0BQ58789562-4AB5C0F5-2113-48E2-9563-6F7860D6B17D
P2860
Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.
@ast
Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.
@en
type
label
Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.
@ast
Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.
@en
prefLabel
Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.
@ast
Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.
@en
P2093
P2860
P1476
Targeting protease-activated receptor-1 with cell-penetrating pepducins in lung cancer.
@en
P2093
Anika Agarwal
Athan Kuliopulos
Caitlin Foley
Jaroslaw Cisowski
Katie O'Callaghan
Larry Brinckerhoff
Lidija Covic
Michael Fogel
P2860
P304
P356
10.1016/J.AJPATH.2011.03.025
P407
P577
2011-05-07T00:00:00Z